Published in JAMA on October 13, 1975
Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature (2010) 6.85
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes (2010) 1.53
Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest (1978) 1.52
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest (1996) 1.41
Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care (2008) 1.36
Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man. Gut (1980) 0.80
Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia (2014) 0.78
Immunocytochemical Localization of Glucose Transporter-2 (GLUT-2) in Pancreatic Islets and Islet Cell Tumors. Endocr Pathol (1999) 0.76
Pancreatic endocrine function in cortisol-treated thyroidectomized calves. J Physiol (1981) 0.75
Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A (1981) 12.86
A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes (1984) 10.09
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med (1995) 4.29
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest (1996) 3.81
The oxygen supply of the foetal brain of the sheep and the effect of asphyxia on foetal respiratory movement. J Physiol (1940) 3.37
Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol (1981) 3.30
Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science (1973) 2.99
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab (1982) 2.45
Müller cell changes in human diabetic retinopathy. Diabetes (1998) 2.34
Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes (1971) 2.32
Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27 beta DNA probe. Blood (1994) 2.24
Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A (1990) 2.18
Tissue effects of glucocorticoids. Am J Med (1972) 2.11
Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci (2000) 2.06
Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol (2001) 1.97
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes (1983) 1.86
Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med (1975) 1.80
Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes (1981) 1.73
MTM1 mutations in X-linked myotubular myopathy. Hum Mutat (2000) 1.72
Contribution of liver and skeletal muscle to alanine and lactate metabolism in humans. Am J Physiol (1990) 1.71
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest (1980) 1.71
Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin Pharmacol Ther (1974) 1.69
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med (1984) 1.61
Self-implanted subcutaneous penile balls--a new phenomenon in Western Europe. Int J Legal Med (1997) 1.60
Diabetes mellitus following rodenticide ingestion in man. JAMA (1978) 1.57
Bone mineral and lean tissue loss after long duration space flight. J Musculoskelet Neuronal Interact (2000) 1.57
Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest (1990) 1.55
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest (1974) 1.55
Hormonal mechanisms of recovery from insulin-induced hypoglycemia in man. Am J Physiol (1979) 1.53
Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes (1985) 1.50
Cushing's disease. Selective trans-sphenoidal resection of pituitary microadenomas. N Engl J Med (1978) 1.48
"Terminal burrowing behaviour"--a phenomenon of lethal hypothermia. Int J Legal Med (1995) 1.48
Effect of selected hexoses, of epinephrine and of glucagon on insulin secretion in man. Diabetes (1966) 1.48
In vivo mapping of amyloid toxicity in Alzheimer disease. Neurology (2009) 1.47
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med (1985) 1.47
Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine. J Clin Invest (1987) 1.47
Photodegradation of imidacloprid. J Agric Food Chem (1999) 1.46
Postoperative studies of adrenal function in primary aldosteronism. J Clin Endocrinol Metab (1966) 1.45
Contribution of long-bone radiographs to the management of congenital syphilis in the newborn infant. Arch Pediatr Adolesc Med (1998) 1.44
Adenosine 3',5'-monophosphate in pancreatic islets: glucose-induced insulin release. Science (1973) 1.43
Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes (1982) 1.39
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes (1984) 1.39
Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol (2000) 1.39
Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest (1988) 1.39
Umbilical cord haematoma as a complication of intrauterine intravascular blood transfusion. Prenat Diagn (1990) 1.39
Immunologic studies of adrenocorticotropic hormone (ACTH): dissociation of biologic and immunologic activities. J Clin Endocrinol Metab (1965) 1.38
Production of insulin resistance by hyperinsulinaemia in man. Diabetologia (1985) 1.36
Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest (1993) 1.35
Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes (1981) 1.35
Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest (1984) 1.34
Stimulation of glucagon secretion by epinephrine in man. J Clin Endocrinol Metab (1973) 1.34
Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol (1999) 1.33
Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy. Mol Biochem Parasitol (2001) 1.33
Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol (1983) 1.31
Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes (1986) 1.31
High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest (1986) 1.30
Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery (1991) 1.29
Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes (1980) 1.29
Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism (1980) 1.28
Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. N Engl J Med (1980) 1.28
Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man. J Clin Endocrinol Metab (1981) 1.28
Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism (1988) 1.27
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest (1990) 1.25
Somatostatin. Physiology and clinical applications. Med Clin North Am (1978) 1.24
Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion. Diabetes (1976) 1.24
Regional muscle loss after short duration spaceflight. Aviat Space Environ Med (1995) 1.23
Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol (1976) 1.23
The antidiuretic action of acetaminophen. Am J Med Sci (1966) 1.22
Experiences with a compound method for estimating the time since death. I. Rectal temperature nomogram for time since death. Int J Legal Med (2000) 1.21
Characterization of the glucagon response to hypoglycemia in man. J Clin Endocrinol Metab (1974) 1.20
Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Pharmacol (1996) 1.20
Molecular deletion patterns in Duchenne and Becker type muscular dystrophy. Hum Genet (1989) 1.20
Stimulation of insulin release by glucagon in noninsulin-dependent diabetics. Metabolism (1966) 1.17
Plasma testosterone stimulation-suppression dynamics in hirsute women. correlation with long-term therapy. Am J Med (1973) 1.17
Effect of diphenylhydantoin on insulin secretion in man. N Engl J Med (1972) 1.17
Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. N Engl J Med (1965) 1.16
Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci (1996) 1.16
Hypoglycemia in IDDM. Diabetes (1989) 1.15
Insulinoma--experience from 1950 to 1995. West J Med (1998) 1.15
Glucose counterregulation and waning of insulin in the Somogyi phenomenon (posthypoglycemic hyperglycemia). N Engl J Med (1984) 1.14
Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. J Clin Invest (1976) 1.13